Nevro Corp
(NVRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -19,274 | -18,960 |
| Depreciation Amortization | 449 | 570 |
| Accounts receivable | -607 | N/A |
| Accounts payable and accrued liabilities | 604 | N/A |
| Other Working Capital | 465 | -5,200 |
| Other Operating Activity | 2,124 | 1,130 |
| Operating Cash Flow | $-16,239 | $-22,460 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -25,921 | N/A |
| PPE Investments | N/A | -30 |
| Other Investing Activity | -200 | 15,300 |
| Investing Cash Flow | $-26,121 | $15,270 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 36 | N/A |
| Other Financing Activity | 47,674 | 1,530 |
| Financing Cash Flow | $47,710 | $1,530 |
| Beginning Cash Position | 5,618 | 11,270 |
| End Cash Position | 10,968 | 5,610 |
| Net Cash Flow | $5,350 | $-5,650 |
| Free Cash Flow | ||
| Operating Cash Flow | -16,239 | -22,460 |
| Free Cash Flow | -16,239 | -22,460 |